ArticleAnnals of the rheumatic diseases2015
When gout goes to the heart: does gout equal a cardiovascular disease risk factor?
Article in Annals of the rheumatic diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Observational
- The Impact of Hyperuricemia on the Progression of Atherosclerotic Cardiovascular Disease.Cureus · 2025Article
- Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques.Rheumatology (Oxford, England) · 2025Article
- Review: The Role of Dual-Energy Computed Tomography in Detecting Monosodium Urate Deposits in Vascular Tissues.Current rheumatology reports · 2024Review
- Association of serum uric acid with male sexual hormones and erectile dysfunction: a bidirectional 2-sample Mendelian randomization analysis.Sexual medicine · 2024Article
- Association between arthritis and cardiovascular risk factors in community-based adults: an opportunity to target cardiovascular risk.BMC cardiovascular disorders · 2022Article
- Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout.Therapeutic advances in musculoskeletal disease · 2022Article
- A glance into the future of gout.Therapeutic advances in musculoskeletal disease · 2022Review
- Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study.The Pan African medical journal · 2022Article
- Hyperuricemia and Cardiovascular Risk.Cureus · 2021Review
- Gout Is Prevalent but Under-Registered Among Patients With Cardiovascular Events: A Field Study.Frontiers in medicine · 2020Article
- Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.Drugs · 2019Review
- Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials.Journal of pain research · 2019Article
- Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome.Frontiers in immunology · 2018Article
- Article
- Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.Arthritis research & therapy · 2017Article
- Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims.Arthritis research & therapy · 2016Article
- The risk of atrial fibrillation in patients with gout: a nationwide population-based study.Scientific reports · 2016Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25603830What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.